NCT03834610View on ClinicalTrials.gov

Daily Oral L-arginine Plus Tadalafil in Diabetic Patients With Erectile Dysfunction

NACompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

October 1, 2017

Primary Completion Date

October 1, 2018

Study Completion Date

October 1, 2018

Conditions
Erectile Dysfunction
Interventions
DRUG

L-arginine 5 gm oral caps

oral L-arginine 5 gm daily for 8 weeks

DRUG

Tadalafil 10 MG

oral daily tadalafil 10mg for 8 weeks

DIAGNOSTIC_TEST

serum testosterone level

measurement of serum testosterone level

DIAGNOSTIC_TEST

HbA1C

measurement of HbA1C levels

DEVICE

penile doppler

penile doppler to measure the degree of erection and penile vasculature

Trial Locations (1)

81528

Aswan University Hospital, Aswān

All Listed Sponsors
lead

Aswan University Hospital

OTHER

NCT03834610 - Daily Oral L-arginine Plus Tadalafil in Diabetic Patients With Erectile Dysfunction | Biotech Hunter | Biotech Hunter